Coherus sells Sandoz its Lucentis biosimilar for $170M to focus on oncology assets news2024-01-22T12:17:00+00:00January 22nd, 2024|Endpoints News|
Apnimed hires Pfizer, Biohaven veteran as chief commercial officernews2024-01-22T12:00:26+00:00January 22nd, 2024|Endpoints News|
Fauna Bio wins NASA grant to explore health effects of hibernation in spacenews2024-01-22T12:00:04+00:00January 22nd, 2024|Endpoints News|
Exclusive: Calluna emerges from the merger of biotechs Oxitope Pharma and Arxx Therapeutics, closes €75M Series A raisenews2024-01-22T09:00:53+00:00January 22nd, 2024|Endpoints News|
Bayer rolls out big changes; 2024’s biotech IPO queue; Dupixent’s ‘next big thing’; 23andMe’s struggle with dual identity; and morenews2024-01-20T11:00:47+00:00January 20th, 2024|Endpoints News|
J&J wins full approval for bladder cancer drugnews2024-01-19T21:27:36+00:00January 19th, 2024|Endpoints News|
AstraZeneca’s Imfinzi combo extends PFS in liver cancer; Novartis shares new details about Lutathera’s PhIIInews2024-01-19T20:59:56+00:00January 19th, 2024|Endpoints News|
DeSantis, Johnson raise flags around Covid boosters as FDA maintains that they’re safe and effectivenews2024-01-19T20:36:13+00:00January 19th, 2024|Endpoints News|
AstraZeneca’s rare blood disorder pill approved in Japannews2024-01-19T20:00:08+00:00January 19th, 2024|Endpoints News|
Former Theranos CEO Elizabeth Holmes is banned from federal health programs for almost a centurynews2024-01-19T19:20:48+00:00January 19th, 2024|Endpoints News|
